Copyright
©The Author(s) 2024.
World J Stem Cells. Jun 26, 2024; 16(6): 641-655
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Table 13 Friedman test results of the changes observed in the Medical Research Council muscle strength scale left values of the patients before and after the intervention
| n | Mean | SD | Mean rank | χ2 | df | P value | |
| Preoperative | 6 | 3.33 | 1.86 | 2.58 | 13.506 | 5 | 0.019 |
| Postoperative 1st wk | 6 | 3.33 | 1.86 | 2.58 | |||
| Postoperative 1st month | 6 | 3.67 | 1.51 | 3.25 | |||
| Postoperative 2nd month | 6 | 4.00 | 1.10 | 4.08 | |||
| Postoperative 4th month | 6 | 4.00 | 1.10 | 4.08 | |||
| Postoperative 1st yr | 6 | 4.17 | 0.98 | 4.42 |
- Citation: Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655
- URL: https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i6.641